Phase I dose escalation study of pegylated liposomal doxorubicin (Caelyx) in combination with topotecan in patients with advanced malignancies.

Ghesquières, Hervé

Phase I dose escalation study of pegylated liposomal doxorubicin (Caelyx) in combination with topotecan in patients with advanced malignancies. [electronic resource] - Investigational new drugs Sep 2006 - 413-21 p. digital

Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article

0167-6997

10.1007/s10637-006-7520-2 doi


Adult
Aged
Antineoplastic Agents--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Doxorubicin--administration & dosage
Female
Humans
Male
Maximum Tolerated Dose
Middle Aged
Neoplasms--drug therapy
Neutropenia--chemically induced
Thrombocytopenia--chemically induced
Topotecan--administration & dosage